Clinical Trial Update: Gastrografin for Treating Small Bowel Obstruction in Children [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Gastrografin in treating pediatric small bowel obstruction has terminated after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Bowel Obstruction

Drugs mentioned

• Gastrografin (diatrizoate meglumine and diatrizoate sodium)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Small Bowel Obstruction | Phase 2, Phase 3 | Status: TERMINATED